PTGX Protagonist Therapeutics, Inc.
Stock · NasdaqGM · United States · Healthcare · US74366E1029
Price
143.37 USD
+2.23%
52-week range
143.37
Low75.55High160.81
Dividend yield—
Market cap9.3B
NowoTrade score
60 Grade A
Price history
Daily prices in USD.
Updated 05 Nov 2026 13:57. Information, not advice.
Key data
- Previous close
- 140.24 USD
- Market cap
- 9.3B
- Exchange
- NasdaqGM
- Country
- United States
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
Dividends
No dividends on record.
Why this score
- Business growth 25.0 / 25
- Quality 11.7 / 25
- Financial strength 16.7 / 20
- Valuation 1.3 / 15
- Analysts 10.0 / 10
- The last full year was a loss
- Revenue growth of 20.1% a year
- ROE of 11%
- Net debt is -12.9× EBITDA
- Free cash flow yield of 1.0%
- P/E 139.2 against 32.1 for its sector
- Analysts' target is +25% from the price
Warnings take points off and some cap the score. In your account the score also considers how the share fits your portfolio.
Follow PTGX and get alerts
Create a free account to add it to your watchlist, set a price alert, see how it fits your portfolio and track your dividends.